L-Arginine: Clinical Trials

4 completed, 3 unknown, 1 active not recruiting, 1 withdrawn. 9 Phase 4.

By phase and status

Phase	Trials	Status
Phase 4	9	Completed 4, Unknown 3, Active not recruiting 1, Withdrawn 1

Follow L-Arginine: new trials by email Literature Review of L-Arginine trials Research Report on L-Arginine

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Safety And Efficacy Of L-Arginine Monotherapy Versus Tadalafil Monotherapy Versus Their Combination In Men With Erectile Dysfunction; A Prospective Randomized Study L-Arginine, Tadalafil 5 mg - Erectile Dysfunctions	Phase 4	Completed	Fayoum University Hospital	180	2024-01-14	2025-04-27
L-arginine to Reduce Sympathetic Nerve Activity in CKD Patients L-Arginine, Placebo - Chronic Kidney Disease	Phase 4	Active not recruiting	The University of Texas at Arlington	15	2018-02-01	2026-06-18
L-arginine Treatment in Mild Hypertension L-arginine, syrup - Hypertension	Phase 4	Unknown	Meir Medical Center	40	2016-09-01	2016-09-09
L-arginine Versus Sildenafil in Children With Beta Thalassemia Associated With Pulmonary Hypertension L-arginine, Sildenafil - Thalassemia	Phase 4	Unknown	Sherief Abd-Elsalam	60	2016-07-01	2018-08-27
Protective Effects of Oral L-Arginine CI-AKI L-arginine, Placebo - Contrast Induced AKI	Phase 4	Unknown	Phramongkutklao College of Medicine and Hospital	112	2014-09-01	2015-05-28
L-Arginine and Spironolactone Trial in Dialysis-Dependent ESRD Spironolactone, L-arginine, Placebo - End Stage Renal Disease, Hemodialysis	Phase 4	Withdrawn	Brigham and Women's Hospital		2013-09-01	2017-05-04
Directed Immuno Nutrition by L-arginine for Critically Ill Patients L-arginine, placebo - Critically Ill	Phase 4	Completed	Assistance Publique - Hôpitaux de Paris	30	2009-11-01	2013-09-18
L-Arginine and Erectile Dysfunction L-arginine, Placebo - Erectile Dysfunction	Phase 4	Completed	Hannover Medical School	57	2003-07-01	2008-10-22
Effect of Arginine on Microcirculation in Patients With Diabetes L-arginine, Placebo Lactose powder - Type 2 Diabetes	Phase 4	Completed	Tameside Hospital NHS Foundation Trust	40	2003-06-01	2013-11-27

Conditions studied

Erectile Dysfunction (2)  ·  Cardiovascular Diseases (1)  ·  Critical Illness (1)  ·  Cross Infection (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Hypertension (1)  ·  Kidney Failure, Chronic (1)  ·  Peripheral Nervous System Diseases (1)  ·  Renal Insufficiency, Chronic (1)  ·  Thalassemia (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Brigham and Women's Hospital (1)  ·  Fayoum University Hospital (1)  ·  Hannover Medical School (1)  ·  Meir Medical Center (1)  ·  Phramongkutklao College of Medicine and Hospital (1)  ·  Sherief Abd-Elsalam (1)  ·  Tameside Hospital NHS Foundation Trust (1)  ·  The University of Texas at Arlington (1)

Countries

Egypt (2)  ·  United States (2)  ·  France (1)  ·  Germany (1)  ·  Israel (1)  ·  Thailand (1)  ·  United Kingdom (1)

Top investigators

Dirk O. Stichtenoth, MD (1)  ·  Eduardo Podjarny, MD (1)  ·  Edward Jude, MD, MRCP (1)  ·  Eman El-Khateeb, Msc (1)  ·  Mohamed El-Shanshoury, Prof (1)  ·  Osama Abd-rab El-Rasol, Prof (1)  ·  Paul J Fadel, PhD (1)  ·  Sahar El-Haggar, Prof (1)  ·  Tarek Mostafa, Ass Prof (1)

Results publications

PMID 15198963, PMID 18626628, PMID 23778831, PMID 33586138, PMID 7519783, PMID 9095088